BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 5:22:00 PM | Browse: 962 | Download: 758
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 3329
Country United States
Received
2013-04-23 09:38
Peer-Review Started
2013-04-23 19:35
To Make the First Decision
2013-07-19 08:53
Return for Revision
2013-07-20 22:45
Revised
Second Decision
2014-01-16 14:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-16 14:49
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-03-12 20:53
Publish the Manuscript Online
2014-03-20 18:58
ISSN 1948-5204 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Autobiography
Article Title Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation
Manuscript Source Invited Manuscript
All Author List H Caitlin A Schonewolf, Monal Mehta, Devora Schiff, Hao Wu, Bruce G Haffty, Vassiliki Karantza and Salma K Jabbour
Funding Agency and Grant Number
Corresponding Author Salma K Jabbour, MD, Departments of Radiation Oncology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, The Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States. jabbousk@umdnj.edu
Key Words Autophagy; Chloroquine; Radiosensitization; Colorectal cancer
Core Tip Autophagy is implicated as a mechanism of resistance to cancer treatment. We hypothesized that chloroquine, a lysosomotropic autophagy inhibitor, would sensitize colorectal cancer (CRC) cell lines to both radiation therapy (RT) alone and concurrent chemoradiation. Our results showed that chloroquine decreased clonogenic survival of CRC cells when given in combination with RT or concurrent 5-fluorouracil and RT. Radiosensitization by chloroquine represents a novel therapeutic approach to enhance treatment efficacy in rectal cancer.
Publish Date 2014-03-20 18:58
Citation Schonewolf CA, Mehta M, Schiff D, Wu H, Haffty BG, Karantza V, Jabbour SK. Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation. World J Gastrointest Oncol 2014; 6(3): 74-82
URL http://www.wjgnet.com/1948-5204/full/v6/i3/74.htm
DOI http://dx.doi.org/10.4251/wjgo.v6.i3.74
Full Article (PDF) wjgo-6-74.pdf
Full Article (Word) wjgo-6-74.doc
Manuscript File 3329-Review.docx
Answering Reviewers 3329-Answering reviewers.pdf
Copyright License Agreement 3329-Copyright assignment.pdf
Peer-review Report 3329-Peer review(s).pdf
Scientific Editor Work List 3329-Scientific editor work list.doc